Prognostic characteristics of the study population.
| Variables | Amyloid Kidney Disease (AKD) (n = 15) | Nonamyloidotic Kidney Disease (NAKD) (n = 10) | p |
|---|---|---|---|
| ESRD/transplant at the study end, % | 73.3 | 20 | 0.015 |
| Time interval from onset of proteinuria to ESRD, yrs | 16.6 ± 11.3 | 8.5 ± 2.1 | 0.359 |
| Time interval from onset of FMF until ESRD, yrs | 41 ± 13.6 | 23.5 ± 2.9 | 0.202 |
| Death, % | 40 | 10 | 0.179 |
| Causes of death | Progression of amyloidosis, n = 3 | Uncontrolled bleeding and pneumonia, n = 1 | |
| Septic foot, n = 1 | |||
| Creutzfeldt-Jacob disease, n = 1 | |||
| Unknown, n = 1 |
ESRD: end stage renal disease; FMF: familial Mediterranean fever.